medline.ch Respirationstrakt Neoplasie

	Investigating the causal link between metformin and lung cancer risk: a two-sample mendelian randomization analysis. BMC Cancer Feng Y, Qiao Y, Li H, Shen B, Ding J, Hua D. PMID: 41549245 [PubMed - as supplied by publisher]
	Bronchial Arterial Chemoembolization Combined with Tislelizumab for Non-Small Cell Lung Cancer: An Exploratory, Prospective, Single-Arm, Phase II Trial. J Vasc Interv Radiol Liang C, Han D, Li H, Wang M, Kuang D, Chen H, Miao H, Chen P, Lu H, Jiao P, Ren J, Han X, Li F, Duan X. PMID: 41548595 [PubMed - as supplied by publisher]
	An evaluation of taletrectinib for the treatment of ROS1+ non-small cell lung cancer. Expert Rev Anticancer Ther Samaeekia R, Arter Z, Nagasaka M. PMID: 41548253 [PubMed - as supplied by publisher]
	The molecular key in exercise-induced lung cancer prevention: insights from Mendelian randomization and SULT1A1-mediated mechanisms. Eur J Med Res Zhu S, Chen Q, Huang C, Tang Z, Yang L, Xu X. PMID: 41547836 [PubMed - as supplied by publisher]
	Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non-small cell lung cancer. J Transl Med Cavaliere S, Fogolari M, Iuliani M, Foderaro S, Cortellini A, Simonetti S, Mingo EC, Calagna S, Russano M, Vincenzi B, Tonini G, Angeletti S, Pantano F. PMID: 41547827 [PubMed - as supplied by publisher]
	PM2.5-modulated targets and miRNAs associated with lung cancer and injury are protected by natural products. Environ Pollut Chuang YT, Yen CY, Liu W, Chang FR, Tsai YH, Chan WH, Chien TM, Chang HW. PMID: 41547393 [PubMed - as supplied by publisher]
	Why are patients with non-small cell lung cancer in stage I-IIIA considered inoperable? A registry-based study from the capital region of Denmark. Eur J Cancer Budolfsen T, Petersen RH, Møller LB, Brabrand J, Saghir Z, Quist M. PMID: 41547178 [PubMed - as supplied by publisher]
	Corrigendum to "Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial" [Radiother. Oncol. 208 (2025) 110907]. Radiother Oncol Dejonckheere CS, Nour Y, Sahlmann J, Engelhart MT, Hammi A, Barth SA, Schimek-Jasch T, Adebahr S, Hecht M, Waller C, Schmid S, Miederer M, Brose A, Binder H, König J, Rimner A, Grosu AL, Nestle U, Gkika E. PMID: 41547133 [PubMed - as supplied by publisher]
	Efficacy of levosalbutamol for lung cancer patients receiving postoperative sputum expectoration by high-frequency chest wall oscillation. Pak J Pharm Sci Wang Y, Leng H. PMID: 41546583 [PubMed - indexed for MEDLINE]
	Improving aerobic capacity in patients with advanced non-small cell lung cancer: study protocol of the 3-armed randomized controlled BREATH trial. Trials De Lazzari N, Wiesweg M, Götte M, Franco J, Mincu RI, Jäger J, Huessler EM, Kuklik N, Stang A, Totzeck M, Tewes M. PMID: 41546104 [PubMed - as supplied by publisher]
	Evaluating the efficacy and safety of antibody-drug conjugates in non-small cell lungÂ cancer: a systematic review andÂ meta-analysis. BMC Cancer Zhang L, Jia H, Niu B. PMID: 41545863 [PubMed - as supplied by publisher]
	Robotic-assisted thoracic surgery for resectable lung cancer: efficacy, safety and surgical approaches - an umbrella review of meta-analyses. BMC Surg Xu Y, Han Q, Wang C, Xu J, Li X, Zhang Q. PMID: 41545856 [PubMed - as supplied by publisher]
	Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial. Signal Transduct Target Ther Wang M, Liu W, Guo H, Long H, Yu B, Zhao G, Wu J, Yue D, Zhao X, Li C, Zhang L, Wang S, Zhang Q, Zhang Z, Wang C. PMID: 41545337 [PubMed - indexed for MEDLINE]
	Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC. J Immunother Cancer Onieva JL, Pérez-Ruiz E, Figueroa-Ortiz LC, Jurado JM, Martínez B, Carlos Benítez J, Rueda-Domínguez A, Barragán I. PMID: 41545302 [PubMed - indexed for MEDLINE]
	Next-generation lung-cancer-on-a-chip: toward personalized therapy, AI, and CRISPR-driven models. Drug Discov Today Hossain NS, Tasnim N, Ferdoush J, Roy A, Saha SC, Saha A. PMID: 41544897 [PubMed - as supplied by publisher]
	Telomere Length Dynamics As a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiotherapy. Int J Radiat Oncol Biol Phys Zhai T, Toprani SM, Dillon-Martin M, Doyle PF, Kang H, Novack C, Liang L, Christiani DC, Kozono DE, Nagel ZD. PMID: 41544677 [PubMed - as supplied by publisher]
	Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial. Lancet Lu S, Wang J, Yang N, Lv D, Chen L, Wu L, Li X, Sun L, Yu Y, Jin B, Yang L, Guo Y, Xu H, Yi T, Zeng A, Dong X, Chen J, Wang Z, Niu H, Cheng Y, Pan P, Deng P, Pan H, Min X, Bai J, Liu L, Zhang T, Li J, Fan S, Shi MM, Mok T, Su W, SACHI Study Group. PMID: 41544643 [PubMed - as supplied by publisher]
	Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib. Clin Lung Cancer Tomasini P, Juan-Vidal O, Califano R, Lin CC, Hulo P, Dooms C, Fang J, Blasco A, Kowalski D, Salinas J, Babu G, Mun TL, Bearz A, Surmont V, Baldotto C, Sharma R, Arrieta O, Stencel K, Card C, Zer A, Massarelli E, Fang B, Mashru S, Schuchard J, Sermon J, Diels J, Chu PL, Withelder M, Bauml JM, Shah S, Baig M, Felip E. PMID: 41544603 [PubMed - as supplied by publisher]
	Adaptive and migration-enhanced tree seed algorithm for multi-threshold CT image segmentation and lung cancer recognition. PLoS One Li C, Jiang J, Ma Z, Yu Z, Li H, Liu J, Li L, Yu Z. PMID: 41544119 [PubMed - indexed for MEDLINE]
	Immunotherapy after EGFRâ€‘TKI treatment in advanced nonâ€‘small cell lung cancer: Current status and future perspectives (Review) . Oncol Rep Ma H, Li L, Jiao C, Cheng Y, He J, Jiang C, Tong Q, Yi D, Zhang Y. PMID: 41543165 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 156541

Seite 1 von 7828



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung